Gyre Therapeutics, Inc. (GYRE)
7.69
-0.18
(-2.29%)
USD |
NASDAQ |
Dec 12, 16:00
7.67
-0.02
(-0.26%)
After-Hours: 20:00
Gyre Therapeutics Market Cap: 740.80M for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.708B |
| Savara, Inc. | 1.408B |
| Exelixis, Inc. | 10.96B |
| Vanda Pharmaceuticals, Inc. | 368.17M |
| Aldeyra Therapeutics, Inc. | 273.14M |
Market Cap Related Metrics
| PE Ratio | 202.37 |
| PS Ratio | 7.072 |
| Price to Book Value | 7.268 |
| Price | 7.69 |
| Earnings Yield | 0.49% |
| Operating PE Ratio | 63.04 |
| Normalized PE Ratio | 388.38 |